50 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals, Inc.
2 May 24
Agios Reports Business Highlights and First Quarter 2024 Financial Results
7:01am
in process development expenses, offset by a decrease in workforce-related expenditures. Selling, General and Administrative (SG&A) Expenses: SG
8-K
EX-99.1
pgzuopt8
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
8-K
EX-99.1
eiwusnyneh7p05iyz
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
adpivcyi 393v
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
EX-99.1
mc8fhlda1awf7f
4 Aug 22
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
7:14am
8-K
EX-99.1
tux46viq6hn3p
5 May 22
Agios Reports Business Highlights and First Quarter 2022 Financial Results
7:21am